Skip to content

Accelerate drug development and boost success rates of clinical trials in immuno-oncology and cell therapies

USZ Zurich
Inselspital
Geninus logo

The problem: drug efficacy gap​

clinical trials

90% of clinical trials fail

50% of failed trials lack clinical efficacy

90 / 50

Actionable biomarkers

approved drugs

90% of approved drugs work only in

50% of the patients

What biomarkers are you looking for?

We discover clinically-relevant biomarkers with single-cell analytics and AI

Disease diagnosis​

Disease diagnosis

Identify novel biomarkers for an early disease diagnosis

Patient stratification​

Patient stratification

Identify patients with higher chance to respond to treatment

Mode of Action​

Mode of
Action

Understand the effect on patient’s immune response

Patient monitoring​

Patient monitoring

Identify prognostic and predictive biomarkers

We revolutionize biomarker discovery with AI and single-cell data

Single-cell resolution icon

Single-cell resolution

We harness the richness of single-cell multiomics data to explain complex biological processes

Artificial Intelligence Icon

Artificial Intelligence

We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis

Biomarker discovery icon

Biomarker discovery

We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity

Gain superior speed, robustness, translatability, and unmatched discovery potential

Gain superior speed, robustness, translatability and unmatched discovery potential

Faster time-to-insights for accelerated biomarker discovery

Sensitive and specific biomarker discovery to identify clinical biomarkers not achievable by conventional analytics

Fully transparent and explainable results allow the translation of biomarker discoveries into simple, affordable clinical assays

Demonstrated best-in-class AI, ensuring superior robustness and reliability of biomarker discoveries

Other questions?
Hemex

Partner Testimonials

Meghan Verschoor

Meghan Verschoor

Associate Director, Data Science in Clinical and Translational Medicine at Turnstone Biologics

“Our team is very impressed with the level of attention to detail and domain knowledge that the Scailyte team brings to our project. We’re excited to continue working with your team!”
Thomas Mehrling

Thomas Mehrling

MD PhD, CEO of MaxiVAX

“Scailyte has been instrumental in analyzing phase IIa clinical single-arm trial data of our most advanced development program. Scailyte’s scientific expertise, communication style and agility are commendable”
Prof. Dr Michael Mueller

Prof. Dr Michael Mueller

Leading Clinician in Women’s Health & Scientific Advisor

“Our current collaboration with Scailyte in the field of women’s health is a truly innovative approach. We are integrating cutting edge technologies to develop biomarkers that will be the basis for impactful diagnostic solutions.”
Pascal Koenig

Pascal Koenig

Entrepreneur & Chairman of the Board of Directors

“As the co-founder and former CEO of Ava Women, I have experienced the power that big datasets have on the healthcare industry. Scailyte’s mission, proven technology and strong expertise have convinced me to join the team. I am delighted to contribute and assist in bringing Scailyte’s solution to patients around the world.”

Recent News

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

Recent News

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

Recent News

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Recent News

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Recent News

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News

01 /04

Transforming Healthcare with Unmatched Biomarker Discovery Power

Experience the game-changing convergence of AI and healthcare. Join us on this journey as we transla...

Read more

LSX Congress USA 2023

Join Scailyte at the LSX Congress USA in Boston on September 13-14 at the Hynes Convention Centre, B...

Read more

Recent News

02 /04

Unveiling ScaiVision's Clinical Potential

Embarking on the last leg of our Discovery Potential series, we're delving into ScaiVision's incredi...

Read more

ScaiDigest Volume 3: Unveiling Immuno-Oncology's Next Frontier

In Volume 3, our very own Diana Stoycheva takes the helm to explore the fascinating realm of single-...

Read more

Recent News

03 /04

Revolutionizing Biomarker Discovery: Unlock the Power of Scailyte's AI platform

Dive into the forefront of scientific advancement with Scailyte's groundbreaking AI platform, ScaiVi...

Read more

Empowering Precision Healthcare with Unparalleled Discovery Potential

From revealing hidden insights to transforming healthcare, ScaiVision is rewriting the rules of disc...

Read more

Recent News

04 /04

Accelerating Discoveries with Scailyte's Speed Strength

In the world of clinical research and development, time is of the essence. Our mission at Scailyte i...

Read more

Nurturing Wellbeing in Our Workspace: Prioritizing People's Growth

At Scailyte, our commitment to ESG goes beyond numbers. It extends to every individual within our vi...

Read more

Recent News